Literature DB >> 28077309

Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancer.

Ziad Omran1, Paula Scaife2, Simon Stewart3, Cyril Rauch4.   

Abstract

The role of the Warburg effect in cancer remains to be elucidated with a resurgence in research efforts over the past decade. Why a cancer cell would prefer to use energy inefficient glycolysis, leading to an alteration of pH both inside and outside of the cell, remains to be uncovered. The development of MDR represents a major challenge in the treatment of cancer and it is explained, so far, by the over expression of drug transporters such as the well-known and archetypal P-glycoprotein (Pgp). However, controversies exist regarding the function of Pgp in multi-drug resistance. We suggest here that Pgp-mediated MDR relies fundamentally on pH alterations mediated by the Warburg effect. Furthermore, we propose that the use of proton pump and/or transporters inhibitors (PPIs/PTIs) in cancer are key to controlling both MDR, i.e. sensitize tumors to antineoplastic agents, and drug-related adverse effects. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug transporter; Membrane biophysics; Pharmacokinetic; Warburg effect

Mesh:

Substances:

Year:  2017        PMID: 28077309     DOI: 10.1016/j.semcancer.2017.01.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  9 in total

1.  Metabolic Reprogramming During Multidrug Resistance in Leukemias.

Authors:  Raphael Silveira Vidal; Julia Quarti; Mariana Figueiredo Rodrigues; Franklin D Rumjanek; Vivian M Rumjanek
Journal:  Front Oncol       Date:  2018-04-04       Impact factor: 6.244

Review 2.  Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies.

Authors:  Salvador Harguindey; Julian Polo Orozco; Khalid O Alfarouk; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2019-09-01       Impact factor: 5.923

Review 3.  Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Authors:  Doris Loh; Russel J Reiter
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

4.  Lipid biophysics and/or soft matter-inspired approach for controlling enveloped virus infectivity.

Authors:  Lamyaa Al-Dalawi; Stephen P Dunham; Cyril Rauch
Journal:  J R Soc Interface       Date:  2022-04-13       Impact factor: 4.118

Review 5.  Tumor acidity: From hallmark of cancer to target of treatment.

Authors:  Alexey Bogdanov; Andrey Bogdanov; Viacheslav Chubenko; Nikita Volkov; Fedor Moiseenko; Vladimir Moiseyenko
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

6.  SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription.

Authors:  Tian Tian; Jiwei Li; Di Shi; Yupeng Zeng; Baohua Yu; Xiaoqiu Li; Ping Wei; Xiaoyan Zhou
Journal:  Cell Death Dis       Date:  2022-09-03       Impact factor: 9.685

7.  Lipoperoxide Nanoemulsion as Adjuvant in Cisplatin Cancer Therapy: In Vitro Study on Human Colon Adenocarcinoma DLD-1 Cells.

Authors:  Stefania Vernazza; Elena Dellacasa; Sara Tirendi; Laura Pastorino; Anna Maria Bassi
Journal:  Nanomaterials (Basel)       Date:  2021-05-21       Impact factor: 5.076

Review 8.  A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Kevin Hardonniere; Daniel Stanciu; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

Review 9.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.